Agios Pharmaceuticals Inc (AGIO)
25.82
+0.04
(+0.16%)
USD |
NASDAQ |
May 26, 16:00
25.81
-0.01
(-0.04%)
After-Hours: 20:00
Agios Pharmaceuticals Shareholders Equity (Quarterly): 1.037B for March 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 1.037B |
| December 31, 2022 | 1.101B |
| September 30, 2022 | 1.050B |
| June 30, 2022 | 1.124B |
| March 31, 2022 | 1.207B |
| December 31, 2021 | 1.292B |
| September 30, 2021 | 1.395B |
| June 30, 2021 | 1.722B |
| March 31, 2021 | 2.297B |
| December 31, 2020 | 399.50M |
| September 30, 2020 | 480.45M |
| June 30, 2020 | 558.46M |
| March 31, 2020 | 625.30M |
| December 31, 2019 | 640.53M |
| September 30, 2019 | 448.29M |
| June 30, 2019 | 532.68M |
| March 31, 2019 | 620.26M |
| December 31, 2018 | 687.54M |
| September 30, 2018 | 760.21M |
| June 30, 2018 | 823.14M |
| March 31, 2018 | 865.59M |
| Date | Value |
|---|---|
| December 31, 2017 | 375.50M |
| September 30, 2017 | 449.81M |
| June 30, 2017 | 508.99M |
| March 31, 2017 | 307.38M |
| December 31, 2016 | 358.59M |
| September 30, 2016 | 401.45M |
| June 30, 2016 | 289.08M |
| March 31, 2016 | 332.37M |
| December 31, 2015 | 345.12M |
| September 30, 2015 | 375.66M |
| June 30, 2015 | 404.16M |
| March 31, 2015 | 426.82M |
| December 31, 2014 | 424.37M |
| September 30, 2014 | 207.75M |
| June 30, 2014 | 200.55M |
| March 31, 2014 | 121.34M |
| December 31, 2013 | 131.48M |
| September 30, 2013 | 142.60M |
| June 30, 2013 | 28.87M |
| March 31, 2013 | 37.12M |
| December 31, 2012 | 43.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
399.50M
Minimum
Dec 2020
2.297B
Maximum
Mar 2021
940.03M
Average
791.68M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cassava Sciences Inc | 204.00M |
| Regeneron Pharmaceuticals Inc | 23.50B |
| Veracyte Inc | 1.081B |
| Karyopharm Therapeutics Inc | -45.17M |
| Xencor Inc | 683.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.151B |
| Total Liabilities (Quarterly) | 114.77M |
| Current Ratio | 17.55 |